The Effectiveness of Wet Cupping on Persistent Non-specific Low Back Pain
- Registration Number
- NCT00925951
- Lead Sponsor
- Korea Institute of Oriental Medicine
- Brief Summary
The hypothesis of this study is that the improvement of Numeric Rating Scale (NRS) for Pain at the end of the study will be greater in the Wet Cupping Treatment group than in the Waiting Control group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 37
- Patients who have had non-specific low back pains at least 12 weeks now.
-
Patients who have low back pain due to specific and known etiological causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome, cauda equinal syndrome).
-
Patients who are inappropriate to the wet cupping treatment.
- AIDS, Active Hepatitis, Tuberculosis, Syphilis
- Patients who regularly take anticoagulants, antiplatelet drugs
- Anemia, thrombocytopenia
- Hemorrhagic disease like hemophilia
- Diabetes
- Severe cardiovascular disease
- Kidney diseases (renal failure, chronic renal disease)
-
Patients who have experiences of wet cupping treatment during last 3 months.
-
Patients who have had treatment for low back pain during last 2 weeks.
-
Patients who are in pregnancy or have plan to conception.
-
Patients who have vertebra surgery or have plan of surgery.
-
Patients who are inappropriate to join this trial judged by the radiologists or specialists.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Wet Cupping Wet Cupping - Wet Cupping Acetaminophen - Waiting Control Acetaminophen They can't use any other specific treatment except exercises and behavior modification (we'll offer a brochure which includes exercise method and directions about behavior modifications).
- Primary Outcome Measures
Name Time Method Numeric Rating Scale (NRS) for pain study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation
- Secondary Outcome Measures
Name Time Method Medication Quantification Scale (MQS) study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation Present Pain Intensity Scale of the McGill Pain Questionaire (PPI) study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation General Assessment of Doctors and Subjects study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation Safety measurement study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation Oswestry Disability Questionnaire (ODQ) study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation
Trial Locations
- Locations (1)
Korea Institue of Oriental Medicine (KIOM), Doonsan Oriental Hospital of Daejeon University
🇰🇷Daejeon, Chungchong, Korea, Republic of